Alahist D

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Alahist D
Generic name
PHENIRAMINE MALEATE, PHENYLEPHRINE HCL
Manufacturer
Poly Pharmaceuticals, Inc.
Product type
HUMAN OTC DRUG
SPL set ID
a1b8533a-ef8b-57cc-e053-2995a90a5d9e
SPL ID
4513de1e-86ae-0275-e063-6294a90a2c6a
Version
6
Effective date
2025-12-03
Source export date
2026-09-28
Source partition
7
Source file
https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/bb1af06e95bcf9567b07e56fcf3a03c0cac3c7c82ff89d4c970881174949e5b7/drug-label-0007-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 05:46:28
Harmonized routes table
Harmonized routes
ORAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS Do not exceed recommended dosage. Do not use this product  if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product. Ask a doctor before use if you have  a breathing problem such as emphysema or chronic bronchitis  glaucoma  trouble urinating due to enlargement of the prostate gland  heart disease  high blood pressure  thyroid disease  diabetes Ask a doctor or pharmacist before use if you are taking sedatives or tranquilizers. When using this product  excitability may occur, especially in children  may cause drowsiness  avoid alcoholic drinks  alcohol, sedatives, and tranquilizers may increase the drowsiness effect  use caution when driving a motor vehicle or operating machinery Stop use and ask a doctor if  nervousness, dizziness, or sleeplessness occur  symptoms do not improve within 7 days or are accompanied by fever If pregnant or breast-feeding, ask a health professional before use.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.